Ad Council

Vena Cava Filter Approved

The Celect Vena Cava Filter designed by Cook Medical received a permanent indication from the Food and Drug Administration. The tool is designed to lower the risk of pulmonary embolism and blood clots stemming from a variety of conditions.

The filter is shaped like a cone; design is intended to support device placement in the center of the vessel. Position is then maintained with struts. The potential of device in-growth outside of intended targets is minimized with the Celect design.

The device already received marketing clearance for permanent placement.  The design was developed recognizing the successes of previous vena cava filters developed by the corporation, including the Bird’s Nest and Gunther Tulip. In Europe and elsewhere, the device was also approved for retrieval. The company has ongoing studies underway to examine additional device indications.

Related stories:

July 31, 2007 Related topics: Cardiology

Today on
Hospital Buyer

Rate of Health Insurance Increasing

The U.S. Census Bureau issued a report, “Income, Poverty, and Health Insurance Coverage in the United States: 2007″...

Heat Exchange Catheter Cleared for Marketing

Alsius, a company dedicated to the development of products to control patient temperature in critical care, recently announced...

Laser Device Launched by Cutera

The Pearl Fractional system for aesthetic treatments was recently launched by Cutera, Incorporated. The company is targeting the...

McKesson Nets Three Hospital Install with Nueterra

The Paragon clinical/financial community hospital information system from McKesson is the solution of choice for Nueterra Healthcare. The...

http://www.hospitalbuyer.com